"10.1371_journal.pone.0125286","plos one","2015-04-30T00:00:00Z","Joshua Manning; Gretchen Reynolds; Zeynep M Saygin; Stefan G Hofmann; Mark Pollack; John D E Gabrieli; Susan Whitfield-Gabrieli","McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Poitras Center for Affective Disorders Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Department of Psychology, Boston University, Boston, Massachusetts, United States of America; Rush University Medical Center, Chicago, Illinois, United States of America","Conceived and designed the experiments: JM JDEG SWG. Performed the experiments: GR ZMS. Analyzed the data: JM SWG. Contributed reagents/materials/analysis tools: SWG. Wrote the paper: JM GR ZMS SGH MP JDEG SWG.","Dr. Pollack is a member of the advisory boards as a consultant for Corcept Therapeutics, Eli Lilly, Ironwood Pharmaceuticals, Medavante, Merck, and Targia Pharmaceuticals. Dr. Pollack holds equity in Doyen Medical, Medavante, Mensante Corporation, Mindsite, and Targia Pharmaceuticals. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","04","Joshua Manning","JM",7,TRUE,3,2,2,7,TRUE,TRUE,FALSE,0,NA,FALSE
